Skip to main content

Risk-Adjusted Operative Mortality for Mitral Valve (MV) Replacement + CABG Surgery

CBE ID
0122
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Fall 2023
Is Under Review
No
Next Maintenance Cycle
Fall 2024
1.3 Measure Description

Percent of patients aged 18 years and older undergoing combined MV Replacement and CABG who die, including both 1) all deaths occurring during the hospitalization in which the procedure was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    • 1.14 Numerator

      Number of patients aged 18 years and older undergoing combined MV Replacement and CABG who die, including both 1) all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and 2) those deaths occurring after discharge from the hospital, but within 30 days of the procedure

    • 1.15 Denominator

      All patients undergoing combined MV Replacement + CABG

    • Exclusions

      N/A

    • OLD 1.12 MAT output not attached
      Attached
      1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Endorsed Surgery Fall Cycle 2018
      Initial Endorsement
      Last Updated
    • Steward
      The Society of Thoracic Surgeons
      Steward Organization POC Email
      [email protected]
    • Risk Adjustment
      Statistical risk model
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off